Dcf Advisers, LLC Becton Dickinson & CO Transaction History

Dcf Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $487,280 - $540,960	-2,000 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$230.08 - $250.94 $230,080 - $250,940	-1,000 Reduced 33.33%	2,000 $503,000
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $953,632 - $1.04 Million	-4,099 Reduced 57.74%	3,000 $730,000
Q1 2021 May 12, 2021	SELL	$232.09 - $256.88 $673,293 - $745,208	-2,901 Reduced 29.01%	7,099 $1.73 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $2.22 Million - $2.46 Million	10,000 New	10,000 $2.5 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.